Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers

The purpose of this study was to prepare and characterize nanocarrier systems, which allow the application of pDNA vaccines and adjuvants to mucosal vaccination. Chitosan from a vegetal source (Agaricus bisporus) and of GMP quality was used to synthesize the derivative 6-O-carboxymethyl-N,N,N-trimet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of drug targeting 2009-09, Vol.17 (8), p.662-670
Hauptverfasser: Heuking, Simon, Adam-Malpel, Sarah, Sublet, Emmanuelle, Iannitelli, Antonio, Stefano, Antonio di, Borchard, Gerrit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 670
container_issue 8
container_start_page 662
container_title Journal of drug targeting
container_volume 17
creator Heuking, Simon
Adam-Malpel, Sarah
Sublet, Emmanuelle
Iannitelli, Antonio
Stefano, Antonio di
Borchard, Gerrit
description The purpose of this study was to prepare and characterize nanocarrier systems, which allow the application of pDNA vaccines and adjuvants to mucosal vaccination. Chitosan from a vegetal source (Agaricus bisporus) and of GMP quality was used to synthesize the derivative 6-O-carboxymethyl-N,N,N-trimethylchitosan (CM-TMC). Toll-like receptor-2 (TLR-2) agonist, Pam3Cys, was synthesized and coupled to CM-TMC through a polyethylene glycol (PEG) spacer. Successively, Pam3Cys decorated nanocarriers were prepared by complexation with plasmid DNA (pDNA) expressing green fluorescence protein (GFP), and characterized with respect to their physicochemical properties and protection of the included plasmid against DNase I enzymatic degradation. In vitro studies using phorbol 12-myristyl 13-acetate (PMA) stimulated macrophage-like THP-1 (mTHP-1) cells were focused on cytotoxicity of both polymers and particles, and their potential to stimulate IL-8 release via the TLR-2 pathway. Our results showed that the TLR-2 functionalized pDNA nanocarriers have the ability to complex and to protect pDNA against enzymatic degradation. pDNA nanocarriers were of around 400 nm in size, and displayed a positive zeta potential of 27.9 ± 1.6 mV. Chitosan, CM-TMC, and Pam3Cys-functionalized CM-TMC polymers displayed cytotoxicity on mTHP1 cells in a concentration-dependent manner, which decreased by 50-fold on complexation with pDNA. In addition, decorated pDNA nanocarriers induced IL-8 secretion by mTHP-1 macrophages, which was increased by 10-fold as compared to nondecorated carriers.
doi_str_mv 10.1080/10611860903106034
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_19694614</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67596898</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-580e11efe4a0eaa62f3e72252c353500c24d72ec43a698b71de0e4de50a761a3</originalsourceid><addsrcrecordid>eNp90MFu1DAQBuAIgWgpPAAX5AuIHgIzduIkgguqgCJVAsEeuEVTZ7LrxbG3diLUt8erXUAIqSfP4ftHnr8oniK8QmjhNYJGbDV0oPIIqrpXnCLIrpRKwf39rLHM4PtJ8SilLQAqjfCwOMFOd5XG6rTYfpvttDiabfAijGKzTOTFRCaG3YbWnMTL1eWXEs_Fkqxfi1VwrnT2B4vIhndziKXM5OprKc8FrYO3aRYDmxBp5kF48sFQjJZjelw8GMklfnJ8z4rVh_eri8vy6vPHTxfvrkpTqWou6xYYkUeuCJhIy1FxI2UtjapVDWBkNTSSMybdtdcNDgxcDVwDNRpJnRUvDmt3MdwsnOZ-ssmwc-Q5LKnXTd3ptmszxAPMt6YUeex30U4Ub3uEft9v_1-_OfPsuHy5nnj4mzgWmsHzI6BkyI2RvLHpj5OYWQN79_bgrB9DnOhniG7oZ7p1If4Oqbv-8eaf-IbJzZvcNPfbsESf-73jil8EKKaJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67596898</pqid></control><display><type>article</type><title>Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers</title><source>MEDLINE</source><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Access via Taylor &amp; Francis</source><creator>Heuking, Simon ; Adam-Malpel, Sarah ; Sublet, Emmanuelle ; Iannitelli, Antonio ; Stefano, Antonio di ; Borchard, Gerrit</creator><creatorcontrib>Heuking, Simon ; Adam-Malpel, Sarah ; Sublet, Emmanuelle ; Iannitelli, Antonio ; Stefano, Antonio di ; Borchard, Gerrit</creatorcontrib><description>The purpose of this study was to prepare and characterize nanocarrier systems, which allow the application of pDNA vaccines and adjuvants to mucosal vaccination. Chitosan from a vegetal source (Agaricus bisporus) and of GMP quality was used to synthesize the derivative 6-O-carboxymethyl-N,N,N-trimethylchitosan (CM-TMC). Toll-like receptor-2 (TLR-2) agonist, Pam3Cys, was synthesized and coupled to CM-TMC through a polyethylene glycol (PEG) spacer. Successively, Pam3Cys decorated nanocarriers were prepared by complexation with plasmid DNA (pDNA) expressing green fluorescence protein (GFP), and characterized with respect to their physicochemical properties and protection of the included plasmid against DNase I enzymatic degradation. In vitro studies using phorbol 12-myristyl 13-acetate (PMA) stimulated macrophage-like THP-1 (mTHP-1) cells were focused on cytotoxicity of both polymers and particles, and their potential to stimulate IL-8 release via the TLR-2 pathway. Our results showed that the TLR-2 functionalized pDNA nanocarriers have the ability to complex and to protect pDNA against enzymatic degradation. pDNA nanocarriers were of around 400 nm in size, and displayed a positive zeta potential of 27.9 ± 1.6 mV. Chitosan, CM-TMC, and Pam3Cys-functionalized CM-TMC polymers displayed cytotoxicity on mTHP1 cells in a concentration-dependent manner, which decreased by 50-fold on complexation with pDNA. In addition, decorated pDNA nanocarriers induced IL-8 secretion by mTHP-1 macrophages, which was increased by 10-fold as compared to nondecorated carriers.</description><identifier>ISSN: 1061-186X</identifier><identifier>EISSN: 1029-2330</identifier><identifier>DOI: 10.1080/10611860903106034</identifier><identifier>PMID: 19694614</identifier><language>eng</language><publisher>London: Informa UK Ltd</publisher><subject>Agaricus - chemistry ; antigen-presenting cells (APC) ; Biological and medical sciences ; Cell Line ; Cell Line, Tumor ; Chitosan ; Chitosan - chemistry ; DNA - administration &amp; dosage ; Dose-Response Relationship, Drug ; General pharmacology ; Green Fluorescent Proteins - genetics ; Humans ; IL-8 release ; Interleukin-8 - metabolism ; Lipoproteins - chemistry ; Macrophages - metabolism ; Medical sciences ; mucosal vaccination ; Nanoparticles ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Plasmids - administration &amp; dosage ; Polyethylene Glycols - chemistry ; THP-1 macrophages ; Toll-like receptor (TLR) ; Toll-Like Receptor 2 - agonists</subject><ispartof>Journal of drug targeting, 2009-09, Vol.17 (8), p.662-670</ispartof><rights>2009 Informa UK Ltd 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-580e11efe4a0eaa62f3e72252c353500c24d72ec43a698b71de0e4de50a761a3</citedby><cites>FETCH-LOGICAL-c434t-580e11efe4a0eaa62f3e72252c353500c24d72ec43a698b71de0e4de50a761a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/10611860903106034$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/10611860903106034$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,59647,59753,60436,60542,61221,61256,61402,61437</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21946704$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19694614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heuking, Simon</creatorcontrib><creatorcontrib>Adam-Malpel, Sarah</creatorcontrib><creatorcontrib>Sublet, Emmanuelle</creatorcontrib><creatorcontrib>Iannitelli, Antonio</creatorcontrib><creatorcontrib>Stefano, Antonio di</creatorcontrib><creatorcontrib>Borchard, Gerrit</creatorcontrib><title>Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers</title><title>Journal of drug targeting</title><addtitle>J Drug Target</addtitle><description>The purpose of this study was to prepare and characterize nanocarrier systems, which allow the application of pDNA vaccines and adjuvants to mucosal vaccination. Chitosan from a vegetal source (Agaricus bisporus) and of GMP quality was used to synthesize the derivative 6-O-carboxymethyl-N,N,N-trimethylchitosan (CM-TMC). Toll-like receptor-2 (TLR-2) agonist, Pam3Cys, was synthesized and coupled to CM-TMC through a polyethylene glycol (PEG) spacer. Successively, Pam3Cys decorated nanocarriers were prepared by complexation with plasmid DNA (pDNA) expressing green fluorescence protein (GFP), and characterized with respect to their physicochemical properties and protection of the included plasmid against DNase I enzymatic degradation. In vitro studies using phorbol 12-myristyl 13-acetate (PMA) stimulated macrophage-like THP-1 (mTHP-1) cells were focused on cytotoxicity of both polymers and particles, and their potential to stimulate IL-8 release via the TLR-2 pathway. Our results showed that the TLR-2 functionalized pDNA nanocarriers have the ability to complex and to protect pDNA against enzymatic degradation. pDNA nanocarriers were of around 400 nm in size, and displayed a positive zeta potential of 27.9 ± 1.6 mV. Chitosan, CM-TMC, and Pam3Cys-functionalized CM-TMC polymers displayed cytotoxicity on mTHP1 cells in a concentration-dependent manner, which decreased by 50-fold on complexation with pDNA. In addition, decorated pDNA nanocarriers induced IL-8 secretion by mTHP-1 macrophages, which was increased by 10-fold as compared to nondecorated carriers.</description><subject>Agaricus - chemistry</subject><subject>antigen-presenting cells (APC)</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Chitosan</subject><subject>Chitosan - chemistry</subject><subject>DNA - administration &amp; dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>General pharmacology</subject><subject>Green Fluorescent Proteins - genetics</subject><subject>Humans</subject><subject>IL-8 release</subject><subject>Interleukin-8 - metabolism</subject><subject>Lipoproteins - chemistry</subject><subject>Macrophages - metabolism</subject><subject>Medical sciences</subject><subject>mucosal vaccination</subject><subject>Nanoparticles</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasmids - administration &amp; dosage</subject><subject>Polyethylene Glycols - chemistry</subject><subject>THP-1 macrophages</subject><subject>Toll-like receptor (TLR)</subject><subject>Toll-Like Receptor 2 - agonists</subject><issn>1061-186X</issn><issn>1029-2330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90MFu1DAQBuAIgWgpPAAX5AuIHgIzduIkgguqgCJVAsEeuEVTZ7LrxbG3diLUt8erXUAIqSfP4ftHnr8oniK8QmjhNYJGbDV0oPIIqrpXnCLIrpRKwf39rLHM4PtJ8SilLQAqjfCwOMFOd5XG6rTYfpvttDiabfAijGKzTOTFRCaG3YbWnMTL1eWXEs_Fkqxfi1VwrnT2B4vIhndziKXM5OprKc8FrYO3aRYDmxBp5kF48sFQjJZjelw8GMklfnJ8z4rVh_eri8vy6vPHTxfvrkpTqWou6xYYkUeuCJhIy1FxI2UtjapVDWBkNTSSMybdtdcNDgxcDVwDNRpJnRUvDmt3MdwsnOZ-ssmwc-Q5LKnXTd3ptmszxAPMt6YUeex30U4Ub3uEft9v_1-_OfPsuHy5nnj4mzgWmsHzI6BkyI2RvLHpj5OYWQN79_bgrB9DnOhniG7oZ7p1If4Oqbv-8eaf-IbJzZvcNPfbsESf-73jil8EKKaJ</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Heuking, Simon</creator><creator>Adam-Malpel, Sarah</creator><creator>Sublet, Emmanuelle</creator><creator>Iannitelli, Antonio</creator><creator>Stefano, Antonio di</creator><creator>Borchard, Gerrit</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Informa Healthcare</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090901</creationdate><title>Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers</title><author>Heuking, Simon ; Adam-Malpel, Sarah ; Sublet, Emmanuelle ; Iannitelli, Antonio ; Stefano, Antonio di ; Borchard, Gerrit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-580e11efe4a0eaa62f3e72252c353500c24d72ec43a698b71de0e4de50a761a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Agaricus - chemistry</topic><topic>antigen-presenting cells (APC)</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Chitosan</topic><topic>Chitosan - chemistry</topic><topic>DNA - administration &amp; dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>General pharmacology</topic><topic>Green Fluorescent Proteins - genetics</topic><topic>Humans</topic><topic>IL-8 release</topic><topic>Interleukin-8 - metabolism</topic><topic>Lipoproteins - chemistry</topic><topic>Macrophages - metabolism</topic><topic>Medical sciences</topic><topic>mucosal vaccination</topic><topic>Nanoparticles</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasmids - administration &amp; dosage</topic><topic>Polyethylene Glycols - chemistry</topic><topic>THP-1 macrophages</topic><topic>Toll-like receptor (TLR)</topic><topic>Toll-Like Receptor 2 - agonists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heuking, Simon</creatorcontrib><creatorcontrib>Adam-Malpel, Sarah</creatorcontrib><creatorcontrib>Sublet, Emmanuelle</creatorcontrib><creatorcontrib>Iannitelli, Antonio</creatorcontrib><creatorcontrib>Stefano, Antonio di</creatorcontrib><creatorcontrib>Borchard, Gerrit</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of drug targeting</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heuking, Simon</au><au>Adam-Malpel, Sarah</au><au>Sublet, Emmanuelle</au><au>Iannitelli, Antonio</au><au>Stefano, Antonio di</au><au>Borchard, Gerrit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers</atitle><jtitle>Journal of drug targeting</jtitle><addtitle>J Drug Target</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>17</volume><issue>8</issue><spage>662</spage><epage>670</epage><pages>662-670</pages><issn>1061-186X</issn><eissn>1029-2330</eissn><abstract>The purpose of this study was to prepare and characterize nanocarrier systems, which allow the application of pDNA vaccines and adjuvants to mucosal vaccination. Chitosan from a vegetal source (Agaricus bisporus) and of GMP quality was used to synthesize the derivative 6-O-carboxymethyl-N,N,N-trimethylchitosan (CM-TMC). Toll-like receptor-2 (TLR-2) agonist, Pam3Cys, was synthesized and coupled to CM-TMC through a polyethylene glycol (PEG) spacer. Successively, Pam3Cys decorated nanocarriers were prepared by complexation with plasmid DNA (pDNA) expressing green fluorescence protein (GFP), and characterized with respect to their physicochemical properties and protection of the included plasmid against DNase I enzymatic degradation. In vitro studies using phorbol 12-myristyl 13-acetate (PMA) stimulated macrophage-like THP-1 (mTHP-1) cells were focused on cytotoxicity of both polymers and particles, and their potential to stimulate IL-8 release via the TLR-2 pathway. Our results showed that the TLR-2 functionalized pDNA nanocarriers have the ability to complex and to protect pDNA against enzymatic degradation. pDNA nanocarriers were of around 400 nm in size, and displayed a positive zeta potential of 27.9 ± 1.6 mV. Chitosan, CM-TMC, and Pam3Cys-functionalized CM-TMC polymers displayed cytotoxicity on mTHP1 cells in a concentration-dependent manner, which decreased by 50-fold on complexation with pDNA. In addition, decorated pDNA nanocarriers induced IL-8 secretion by mTHP-1 macrophages, which was increased by 10-fold as compared to nondecorated carriers.</abstract><cop>London</cop><pub>Informa UK Ltd</pub><pmid>19694614</pmid><doi>10.1080/10611860903106034</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1061-186X
ispartof Journal of drug targeting, 2009-09, Vol.17 (8), p.662-670
issn 1061-186X
1029-2330
language eng
recordid cdi_pubmed_primary_19694614
source MEDLINE; Taylor & Francis Medical Library - CRKN; Access via Taylor & Francis
subjects Agaricus - chemistry
antigen-presenting cells (APC)
Biological and medical sciences
Cell Line
Cell Line, Tumor
Chitosan
Chitosan - chemistry
DNA - administration & dosage
Dose-Response Relationship, Drug
General pharmacology
Green Fluorescent Proteins - genetics
Humans
IL-8 release
Interleukin-8 - metabolism
Lipoproteins - chemistry
Macrophages - metabolism
Medical sciences
mucosal vaccination
Nanoparticles
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Plasmids - administration & dosage
Polyethylene Glycols - chemistry
THP-1 macrophages
Toll-like receptor (TLR)
Toll-Like Receptor 2 - agonists
title Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A10%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stimulation%20of%20human%20macrophages%20(THP-1)%20using%20Toll-like%20receptor-2%20(TLR-2)%20agonist%20decorated%20nanocarriers&rft.jtitle=Journal%20of%20drug%20targeting&rft.au=Heuking,%20Simon&rft.date=2009-09-01&rft.volume=17&rft.issue=8&rft.spage=662&rft.epage=670&rft.pages=662-670&rft.issn=1061-186X&rft.eissn=1029-2330&rft_id=info:doi/10.1080/10611860903106034&rft_dat=%3Cproquest_pubme%3E67596898%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67596898&rft_id=info:pmid/19694614&rfr_iscdi=true